EUVIMEDEUVIMED entdecken
Open Access

Venlafaxine extended release (XR) in the treatment of panic disorder

Kevin Kjernisted, Diane McIntosh

Therapeutics and Clinical Risk Management · 2007-02 · 3 (1) · 59-69

DOI: 10.2147/tcrm.2007.3.1.59 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Therapeutics and Clinical Risk Management, 2007-02. Verfasst von Kevin Kjernisted und 1 weiteren Autor:innen. Beteiligte Einrichtung: University of British Columbia Vancouver, British Columbia, Canada. Die Arbeit wurde bisher 15-mal zitiert (Crossref) und nennt 78 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar.

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Panic disorder is a chronic, recurrent illness, with a lifetime prevalence of about 5%. It is associated with substantial functional impairment, and studies suggest that treatment with medication alone (and no instruction in exposure to feared and avoided situations) is less than optimal. In fact, 40%-90% of patients in long-term follow-up studies in the late 1980s and early 1990s, treated with antidepressants or high potency benzodiazepines alone, remained somewhat symptomatic. Venlafaxine extended release (XR) was effective and well tolerated in both the short-term and long-term treatment of panic disorder. In 12-week trials, venlafaxine XR was significantly more effective than placebo in achieving a panic-free state (54%-70% vs 34%-48%, p

Autor:innen und Institutionen

  • University of British Columbia Vancouver, British Columbia, Canada.

Zitieren

APA

Kjernisted, K., & McIntosh, D. (2007). Venlafaxine extended release (XR) in the treatment of panic disorder. Therapeutics and Clinical Risk Management, 3(1), 59-69. https://doi.org/10.2147/tcrm.2007.3.1.59

Vancouver

Kjernisted K, McIntosh D. Venlafaxine extended release (XR) in the treatment of panic disorder. Therapeutics and Clinical Risk Management. 2007;3(1):59-69. doi:10.2147/tcrm.2007.3.1.59

BibTeX
@article{Kjernisted2007,
  author = {Kjernisted, Kevin and McIntosh, Diane},
  title = {Venlafaxine extended release (XR) in the treatment of panic disorder},
  journal = {Therapeutics and Clinical Risk Management},
  year = {2007},
  volume = {3},
  number = {1},
  pages = {59--69},
  doi = {10.2147/tcrm.2007.3.1.59}
}
Kostenlos starten →